| 0 |
CATHETERISATION CARDIAC ABNORMAL |
1 |
0.0037 |
| 1 |
OESOPHAGEAL MOTILITY DISORDER |
1 |
0.0028 |
| 2 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
1 |
0.0011 |
| 3 |
MUSCLE SWELLING |
1 |
0.0011 |
| 4 |
WAIST CIRCUMFERENCE INCREASED |
1 |
0.0010 |
| 5 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
1 |
0.0007 |
| 6 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 7 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 8 |
DEVICE POWER SOURCE ISSUE |
1 |
0.0003 |
| 9 |
BRAIN DEATH |
1 |
0.0003 |
| 10 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 11 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 12 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 13 |
HEMIPLEGIA |
1 |
0.0001 |
| 14 |
ERUCTATION |
2 |
0.0001 |
| 15 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 16 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 17 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 18 |
HIATUS HERNIA |
1 |
0.0001 |
| 19 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 20 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 21 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 22 |
EATING DISORDER |
1 |
0.0000 |
| 23 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 24 |
EYE PAIN |
2 |
0.0000 |
| 25 |
ANGINA PECTORIS |
1 |
0.0000 |
| 26 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 27 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 28 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 29 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 30 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 31 |
TINNITUS |
1 |
0.0000 |
| 32 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 33 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 34 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 35 |
LUNG DISORDER |
1 |
0.0000 |
| 36 |
DRY EYE |
1 |
0.0000 |
| 37 |
FLUID RETENTION |
1 |
0.0000 |
| 38 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 39 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 40 |
LETHARGY |
1 |
0.0000 |
| 41 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 42 |
DRY SKIN |
2 |
0.0000 |
| 43 |
WEIGHT DECREASED |
4 |
0.0000 |
| 44 |
INJURY |
1 |
0.0000 |
| 45 |
HOT FLUSH |
1 |
0.0000 |
| 46 |
CARDIAC FAILURE |
1 |
0.0000 |
| 47 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 48 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 49 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 50 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 51 |
TACHYCARDIA |
1 |
0.0000 |
| 52 |
MIGRAINE |
1 |
0.0000 |
| 53 |
DYSPEPSIA |
1 |
0.0000 |
| 54 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 55 |
ILLNESS |
1 |
0.0000 |
| 56 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 57 |
HAEMORRHAGE |
1 |
0.0000 |
| 58 |
HYPERTENSION |
2 |
0.0000 |
| 59 |
INFLUENZA |
1 |
0.0000 |
| 60 |
VISION BLURRED |
1 |
0.0000 |
| 61 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 62 |
DRUG INTERACTION |
1 |
0.0000 |
| 63 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 64 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 65 |
MYALGIA |
1 |
0.0000 |
| 66 |
MUSCLE SPASMS |
1 |
0.0000 |
| 67 |
SOMNOLENCE |
1 |
0.0000 |
| 68 |
HEADACHE |
3 |
0.0000 |
| 69 |
DECREASED APPETITE |
1 |
0.0000 |
| 70 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 71 |
DIZZINESS |
2 |
0.0000 |
| 72 |
INSOMNIA |
1 |
0.0000 |
| 73 |
ANXIETY |
1 |
0.0000 |
| 74 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 75 |
ASTHENIA |
1 |
0.0000 |
| 76 |
PRURITUS |
1 |
0.0000 |
| 77 |
VOMITING |
1 |
0.0000 |
| 78 |
DYSPNOEA |
1 |
0.0000 |
| 79 |
DIARRHOEA |
1 |
0.0000 |
| 80 |
FATIGUE |
1 |
0.0000 |
| 81 |
NAUSEA |
1 |
0.0000 |
| 82 |
OFF LABEL USE |
1 |
0.0000 |
| 83 |
DRUG INEFFECTIVE |
1 |
0.0000 |